Breast Cancer Clinical Trials in Tennessee

Showing 301-320 of 351 trials

Neoadjuvant Sunitinib With Paclitaxel/Carboplatin in Patients With Triple-Negative Breast Cancer

NCT00887575

This trial will examine the combination of sunitinib plus paclitaxel and carboplatin as neoadjuvant treatment for locally advanced breast cancer.

Breast Cancer

SCRI Development Innovations, LLC54 participantsStarted Jun 2009

Fort Lauderdale, Florida, United States • Fort Myers, Florida, United States • Fort Myers, Florida, United States +11 more locations

COMPLETEDPHASE229 miles

Docetaxel Plus Imatinib Mesylate in Metastatic Breast Cancer

NCT00193180

This trial evaluates the novel combination of docetaxel with imatinib as first or second line therapy in advanced breast cancer with the aim of achieving higher effectiveness and potentially reducing side effects.

Breast Cancer

SCRI Development Innovations, LLC37 participantsStarted May 2005

Gainesville, Georgia, United States • Louisville, Kentucky, United States • Baton Rouge, Louisiana, United States +3 more locations

Neoadjuvant Sunitinib With Paclitaxel/Carboplatin in Patients With Triple-Negative Breast Cancer

Docetaxel Plus Imatinib Mesylate in Metastatic Breast Cancer

Breast Cancer Trials in Other Cities

Erlotinib and Everolimus in Treating Patients With Metastatic Breast Cancer

Radiation Therapy in Treating Patients With Bone Metastases From Breast or Prostate Cancer

RO4929097 And Exemestane in Treating Pre- and Postmenopausal Patients With Advanced or Metastatic Breast Cancer

Panitumumab, Gemcitabine and Carboplatin in Triple-Negative Metastatic Breast Cancer

Neoadjuvant Ixabepilone/Carboplatin/Trastuzumab in HER2-Positive Locally Advanced Breast Cancer

Phase I/II Trial of Sorafenib Plus Ixabepilone in HER2-Negative Metastatic Breast Cancer

Study of NK012 and Carboplatin in Solid Tumors With Dose Expansion in Triple Negative Breast Cancer

Bioequivalence Study of IG-001 Versus Nab-paclitaxel in Metastatic or Locally Recurrent Breast Cancer

A Study of AC Followed by a Combination of Paclitaxel Plus Trastuzumab or Lapatinib or Both Given Before Surgery to Patients With Operable HER2 Positive Invasive Breast Cancer

Brain Function in Premenopausal Women Receiving Tamoxifen With or Without Ovarian Function Suppression for Early-Stage Breast Cancer on Clinical Trial IBCSG 24-02

Efficacy and Safety of Everolimus in Combination Therapy, in Patients With HER2-overexpressing Metastatic Breast Cancer

Thyroid Dysfunction in Women With Newly Diagnosed Breast Cancer Compared to Healthy Volunteers

Zoledronate, Calcium, and Vitamin D in Preventing Bone Loss in Women Receiving Adjuvant Chemotherapy for Breast Cancer

Gabapentin With or Without Antidepressants in Treating Hot Flashes in Women Who Have Had Breast Cancer or Have Concerns About Taking Hormone Therapy

Changes in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast Cancer

ICI 182780 in Treating Women With Metastatic Breast Cancer

Gabapentin For the Control of Hot Flashes in Women With Breast Cancer

A Pharmacodynamics Pre-surgical Study of LEE011 in Early Breast Cancer Patients (MONALEESA-1)

Other Conditions in Tennessee